Could Psychedelics Become Tripless?
Short Wave
00:00
The Quest for Non-Hallucinogenic Psychedelics
This chapter explores the development of non-hallucinogenic psychedelic drugs designed for therapeutic use, highlighting their potential benefits in treating conditions like depression. It features discussions on ongoing clinical trials, particularly focusing on the promising drug DLX1, while addressing the broader implications and debates within this emerging field.
Transcript
Play full episode
